IMMUFELLOW · Interdisciplinary and Intersectoral Research Fellowship Program for Future Leaders in Immunology

Lines connect the coordinator with its partners.

Project objective

Interdisciplinary and Intersectoral Research Fellowship Program for Future Leaders in Immunology (IMMUFELLOW) is an innovative postdoctoral training initiative of the University of Turku (UTU) and Åbo Akademi University (ÅAU) in Turku, Finland. Immune-related diseases, such as infections, atherosclerosis, and cancer, are increasing in prevalence and pose major societal/economic challenges. IMMUFELLOW will cultivate experts and leaders in immunology who will drive research advancements to address unmet needs in preventing and treating immune-mediated diseases. IMMUFELLOW will build on UTU’s/ÅAU’s excellence in leadership development, advanced education models, and beyond state-of-the-art immunological research ecosystem and infrastructure. With 22 experienced postdoctoral researchers (ERs) recruited for 36-month terms via a rigorous, merit-based selection process, this initiative prioritizes interdisciplinary and intersectoral research, aligning with the European Charter and Code. Supported by the InFLAMES Flagship, IMMUFELLOW fills a critical void in postdoctoral training, offering a structured program integrating science, technology and entrepreneurship. IMMUFELLOW ensures comprehensive research excellence and training opportunities beyond academia, with the following key features:Support and Mentoring: Each ER benefits from a dedicated intersectoral mentoring team, access to exceptional training opportunities, and monthly seminars/networking events.Sector-Wide Involvement: Beyond academia, fellows explore research, training, and development opportunities in corporate settings, with education on regulatory standards/good practices in diagnostics, drug development, and manufacturing.Entrepreneurial Skills: Equipping fellows with the skills and knowledge to thrive in diverse professional environments.IMMUFELLOW thus stands at the forefront of postdoctoral training, fostering the next generation of leaders in immunology and driving impactful research advancements.

Original text from CORDIS.

Participants

• TURUN YLIOPISTO · TurkuCoordinatorFinland
• ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS · DERIO VIZCAYASpain
• Aurlide Ltd · TurkuFinland
• BRINTER AM TECHNOLOGIES OY · TURKUFinland
• BUSINESS TURKU OY AB · TURKUFinland
• Bayer Oy · TurkuFinland
• Biovian Oy · TurkuFinland
• ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM · RotterdamNetherlands
• EURO-BIOIMAGING ERIC · TurkuFinland
• FARON PHARMACEUTICALS OY · TurkuFinland
• FINNADVANCE OY · HelsinkiFinland
• FONDAZIONE TOSCANA LIFE SCIENCES · SienaItaly
• FUJIREBIO DIAGNOSTICS AB · GoeteborgSweden
• FUNDACAO CALOUSTE GULBENKIAN · LisboaPortugal
• KAROLINSKA INSTITUTET · STOCKHOLMSweden
• KING'S COLLEGE LONDON · LondonUnited Kingdom
• KOBENHAVNS UNIVERSITET · KOBENHAVNDenmark
• MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV · MUNCHENGermany
• MEDIZINISCHE UNIVERSITAET WIEN · WienAustria
• MISVIK BIOLOGY OY · TURKUFinland
• ORION OYJ · EspooFinland
• Olo Health Oy · TurkuFinland
• Radiometer Turku Oy · TurkuFinland
• Roche Oy · EspooFinland
• TARTU ULIKOOL · TartuEstonia
• TECHNISCHE UNIVERSITEIT EINDHOVEN · EindhovenNetherlands
• THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN · DublinIreland
• THE QUEEN'S UNIVERSITY OF BELFAST · BELFASTUnited Kingdom
• THE TRUSTEES OF BOSTON UNIVERSITY · BOSTON MAUnited States
• THE UNIVERSITY OF OSAKA · OsakaJapan
• UGA RESEARCH FOUNDATION INC NON PROFIT CORP · ATHENSUnited States
• UNIVERSITA DEGLI STUDI DI SIENA · SienaItaly
• UNIVERSITE D'AIX MARSEILLE · MarseilleFrance
• UNIVERSITEIT GENT · GentBelgium
• UNIVERSITY COLLEGE LONDON · LondonUnited Kingdom
• UPM-KYMMENE OYJ · HELSINKIFinland
• Uniogen Oy · TurkuFinland

Links

• View on CORDIS
• DOI: 10.3030/101217173